Alyeska Investment Group
BHST

Alyeska Investment Group’s BioHarvest Sciences BHST Stock Holding History

Alyeska Investment Group’s Portfolio BHST Stock Details BHST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Sell
581,441
-175,623
-23% -$670K ﹤0.01% 585
2026
Q1 		$3.29M Hold
757,064
– – 0.01% 518
2025
Q4 		$3.93M Buy
+757,064
New +$6.05M 0.01% 481

Other funds holding BHST

TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $1.05B AUM 22.99% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Alyeska Investment Group's BHST Position: Q2 2026 in Review

Alyeska Investment Group reduced its BioHarvest Sciences (BHST) stake by 23% in Q2 2026, selling an estimated $670K and leaving 581,441 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Alyeska Investment Group first reported a position in BHST in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.93M in Q4 2025. 19 funds tracked by Wall St. Rank hold BHST as of Q2 2026.

  • Alyeska Investment Group held 581,441 shares of BioHarvest Sciences worth $1.66M as of Q2 2026.
  • Alyeska Investment Group sold 175,623 BioHarvest Sciences shares in Q2 2026, an estimated $670K.
  • BioHarvest Sciences made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #585 holding.
  • Alyeska Investment Group first reported a position in BioHarvest Sciences in Q4 2025 and has held it in 3 quarters since.
  • Alyeska Investment Group's BioHarvest Sciences position peaked at $3.93M in Q4 2025.
  • 19 funds tracked by Wall St. Rank held BioHarvest Sciences as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.